BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 29, 2004
View Archived Issues
Cell Therapeutics Adds To Cash With $42.8M Offering
Laden with the expense of pivotal trials, Cell Therapeutics Inc. raised $42.8 million to give it the reserves to last through 2005. (BioWorld Today)
Read More
With Antegren Launch Expected, Biogen Idec Tops 2Q Estimates
Read More
MannKind IPO Prices Within Range; Shares Close Higher
Read More
New BioDefense Guide Released With 37 Company Success Stories
Read More
Lexicon, Takeda In Agreement For High Blood Pressure Drugs
Read More
Other News To Note
Read More